These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36685888)

  • 21. Comprehensive analysis of ETS1 expression and its prognostic value in clear cell renal cell carcinoma.
    Mo M; Zhu Q; Yang L; Deng Y; Yu Y; Zhou Z
    Am J Transl Res; 2024; 16(4):1062-1080. PubMed ID: 38715839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
    Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
    Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
    Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Zhang WT; Gong YM; Zhang CY; Pan JS; Huang T; Li YX
    Biomed Res Int; 2022; 2022():9196540. PubMed ID: 36105937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma.
    Zhang C; Zeng J; Ye C; Tian K; Xian Z
    Transl Cancer Res; 2024 Jan; 13(1):150-172. PubMed ID: 38410230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
    Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
    Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate biomarker
    Lv Q; Xiao W; Xiong Z; Shi J; Miao D; Meng X; Yuan H; Yang H; Zhang X
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1176-1190. PubMed ID: 34856762
    [No Abstract]   [Full Text] [Related]  

  • 30. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
    Zhang F; Liu L; Wu P; Li S; Wei D
    Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining.
    Xu Z; Wang Y; Xu J; Ang X; Ge N; Xu M; Pei C
    Heliyon; 2023 Feb; 9(2):e13543. PubMed ID: 36846683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study.
    Chu J; Liu W; Hu X; Zhang H; Jiang J
    Health Sci Rep; 2023 Dec; 6(12):e1646. PubMed ID: 38045624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
    Lu G; Zhou Y; Zhang C; Zhang Y
    Front Genet; 2021; 12():671585. PubMed ID: 34149814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased
    Chen Z; Lv Y; He L; Wu S; Wu Z
    Front Mol Biosci; 2021; 8():657672. PubMed ID: 35096961
    [No Abstract]   [Full Text] [Related]  

  • 36. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
    Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
    Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Chen P; Zhang Z; Chen X
    Med Sci Monit; 2020 Oct; 26():e926755. PubMed ID: 33024069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
    Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
    Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.